Precision Transplant Medicine Market

Kidney transplantation leads the precision transplant medicine market with a 35.2% share in 2026 by organ type, followed by genomic profiling at 36.4% by technology and transplant centers at 35.6% by end user. Adoption reflects demand for personalized transplant management, while high testing costs and complex clinical integration remain key constraints.